Tag: Onivyde
Ipsen: FDA approval for the therapeutic regimen including Onivyde, a potential new first-line reference treatment in metastatic pancreatic adenocarcinoma
By Claude Leguilloux Published on 02/14/2024 at 7:27 a.m. (Boursier.com) — Ipsen announces that the American authorities (Food…
Ipsen: a dossier accepted by the FDA for Onivyde – 06/15/2023 at 07:08
(CercleFinance.com) – Ipsen announces that the United States FDA has accepted its application for an additional indication for its Onivyde in combination, as a potential first-line treatment in patients with…
Ipsen: FDA accepts additional indication request for Onivyde
By Alexandra Saintpierre Published on 06/14/2023 at 22:11 Photo credit © Merrimack (Boursier.com) — Ipsen indicates that the…
Ipsen: positive phase III data for Onivyde
Through Olivier Cheilan Published on 01/20/2023 at 5:57 p.m. (Boursier.com) —…